Skip to Main Content

Paper Details

Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial.
Am J Gastroenterol
10
2023
Filgotinib, Inflammatory Bowel Disease, Janus kinase 1, Patients, UC, Ulcerative Colitis, filgotinib, patient, patients, rectal, ulcerative colitis
Author NameAffiliation
William J SandbornUniversity of California San Diego
Stefan SchreiberUniversity Hospital Schleswig-Holstein
Edward V LoftusMayo Clinic College of Medicine and Science
  • 1 - 3

Datasets

Release 1.2